Literature DB >> 29712772

SOCS1 and SOCS3 Target IRF7 Degradation To Suppress TLR7-Mediated Type I IFN Production of Human Plasmacytoid Dendritic Cells.

Chun-Feng Yu1, Wen-Ming Peng1, Martin Schlee2, Winfried Barchet2, Anna Maria Eis-Hübinger3, Waldemar Kolanus4, Matthias Geyer5, Sebastian Schmitt5, Folkert Steinhagen6, Johannes Oldenburg7, Natalija Novak8.   

Abstract

Type I IFN production of plasmacytoid dendritic cells (pDCs) triggered by TLR-signaling is an essential part of antiviral responses and autoimmune reactions. Although it was well-documented that members of the cytokine signaling (SOCS) family regulate TLR-signaling, the mechanism of how SOCS proteins regulate TLR7-mediated type I IFN production has not been elucidated yet. In this article, we show that TLR7 activation in human pDCs induced the expression of SOCS1 and SOCS3. SOCS1 and SOCS3 strongly suppressed TLR7-mediated type I IFN production. Furthermore, we demonstrated that SOCS1- and SOCS3-bound IFN regulatory factor 7, a pivotal transcription factor of the TLR7 pathway, through the SH2 domain to promote its proteasomal degradation by lysine 48-linked polyubiquitination. Together, our results demonstrate that SOCS1/3-mediated degradation of IFN regulatory factor 7 directly regulates TLR7 signaling and type I IFN production in pDCs. This mechanism might be targeted by therapeutic approaches to either enhance type I IFN production in antiviral treatment or decrease type I IFN production in the treatment of autoimmune diseases.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29712772     DOI: 10.4049/jimmunol.1700510

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Triggering of the cGAS-STING Pathway in Human Plasmacytoid Dendritic Cells Inhibits TLR9-Mediated IFN Production.

Authors:  Pratik Deb; Jihong Dai; Sukhwinder Singh; Evelyne Kalyoussef; Patricia Fitzgerald-Bocarsly
Journal:  J Immunol       Date:  2020-05-29       Impact factor: 5.422

2.  Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma.

Authors:  Chen Zhu; Cunyi Zou; Gefei Guan; Qing Guo; Zihao Yan; Tianqi Liu; Shuai Shen; Xiaoyan Xu; Chen Chen; Zhiguo Lin; Wen Cheng; Anhua Wu
Journal:  Oncoimmunology       Date:  2019-06-12       Impact factor: 8.110

3.  Overlapping transcriptional programs promote survival and axonal regeneration of injured retinal ganglion cells.

Authors:  Anne Jacobi; Nicholas M Tran; Wenjun Yan; Inbal Benhar; Feng Tian; Rebecca Schaffer; Zhigang He; Joshua R Sanes
Journal:  Neuron       Date:  2022-06-28       Impact factor: 18.688

4.  Duck Tembusu Virus Inhibits Type I Interferon Production through the JOSD1-SOCS1-IRF7 Negative-Feedback Regulation Pathway.

Authors:  Shanzhi Huang; Juan Huang; Min Cui; Xuedong Wu; Mingshu Wang; Dekang Zhu; Shun Chen; Mafeng Liu; Xinxin Zhao; Ying Wu; Qiao Yang; Shaqiu Zhang; Xumin Ou; Sai Mao; Qun Gao; Yanling Yu; Bin Tian; Yunya Liu; Ling Zhang; Zhongqiong Yin; Bo Jing; Xiaoyue Chen; Anchun Cheng; Renyong Jia
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

Review 5.  Interplay between SARS-CoV-2 and the type I interferon response.

Authors:  Margarida Sa Ribero; Nolwenn Jouvenet; Marlène Dreux; Sébastien Nisole
Journal:  PLoS Pathog       Date:  2020-07-29       Impact factor: 6.823

Review 6.  Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity.

Authors:  Diego R Hijano; Luan D Vu; Lawrence M Kauvar; Ralph A Tripp; Fernando P Polack; Stephania A Cormier
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

Review 7.  Protective Effects of Probiotic Consumption in Cardiovascular Disease in Systemic Lupus Erythematosus.

Authors:  Néstor de la Visitación; Iñaki Robles-Vera; Marta Toral; Juan Duarte
Journal:  Nutrients       Date:  2019-11-05       Impact factor: 5.717

8.  Neutralizing interferon-α blocks inflammation-mediated vascular injury via PI3K and AMPK in systemic lupus erythematosus.

Authors:  Xuewei Ding; Wei Xiang; Ren Yi; Xiaoyan Huang; Qiuyu Lin; Xiaojie He
Journal:  Immunology       Date:  2021-06-20       Impact factor: 7.215

9.  MicroRNA-345-5p regulates depression by targeting suppressor of cytokine signaling 1.

Authors:  Yulan Liu; Jun Yu; Xinrui Wang; Jicheng Dong
Journal:  Brain Behav       Date:  2020-07-30       Impact factor: 2.708

10.  Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity.

Authors:  Amalia Lamana; Ricardo Villares; Iria V Seoane; Nuria Andrés; Pilar Lucas; Paul Emery; Edward M Vital; Ana Triguero-Martínez; Ana Marquez; Ana M Ortiz; Robin Maxime; Carmen Martínez; Javier Martín; Rosa P Gomariz; Frederique Ponchel; Isidoro González-Álvaro; Mario Mellado
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.